155 related articles for article (PubMed ID: 32974151)
1. Different Clinicopathological Characteristics and Prognostic Factors for Occult and Non-occult Breast Cancer: Analysis of the SEER Database.
Huang KY; Zhang J; Fu WF; Lin YX; Song CG
Front Oncol; 2020; 10():1420. PubMed ID: 32974151
[No Abstract] [Full Text] [Related]
2. Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study.
Ge LP; Liu XY; Xiao Y; Gou ZC; Zhao S; Jiang YZ; Di GH
Cancer Manag Res; 2018; 10():4381-4391. PubMed ID: 30349371
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Occult Breast Cancer Patients.
Qu J; Li C; Liu M; Wang Y; Feng Z; Li J; Wang W; Wu F; Zhang S; Zhao X
J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176539
[TBL] [Abstract][Full Text] [Related]
4. Reconceptualizing the clinicopathological features, locoregional therapy and prognostic factors of occult breast cancer in the era of molecular subtyping.
Ye X; Yang L; He Q; Lin X; Wang J; Cui R; Xu C
Women Health; 2023 Feb; 63(2):105-114. PubMed ID: 36576239
[TBL] [Abstract][Full Text] [Related]
5. Survival analysis and nomogram for early-stage occult breast cancer with positive lymph nodes based on the SEER database.
Man X; Xu H; Wang H; Zhao J; Chen X; Yin S; Tan Q; Huang J; Sun S; Zhou D; Zheng F; Liu T; Song L; Zhang B; Li N; Li H
Ann Transl Med; 2022 Dec; 10(24):1351. PubMed ID: 36660717
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors and a Model for Occult Breast Cancer: A Population-Based Cohort Study.
Zhang D; Zhai J; Li L; Wu Y; Ma F; Xu B
J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431280
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features, psychological status, and prognosis of 33 patients with occult breast cancer.
Wang HM; Yu AY; Li LL; Ma LY; Cao MH; Yang YL; Qin XB; Tang JJ; Han ZX
World J Psychiatry; 2024 Jan; 14(1):76-87. PubMed ID: 38327892
[TBL] [Abstract][Full Text] [Related]
8. The effect of local therapy on breast cancer-specific mortality of women with occult breast cancer and advanced nodal disease (N2/N3): a population analysis.
Johnson HM; Irish W; Vohra NA; Wong JH
Breast Cancer Res Treat; 2019 Aug; 177(1):155-164. PubMed ID: 31127469
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical characteristics between occult and non-occult breast cancer.
Ping S; Ming WH; Bin SH; Wen WD; Cheng Q; Jun CC; Bin HY; Jian CZ
J BUON; 2014; 19(3):662-6. PubMed ID: 25261649
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics and treatment outcomes of occult breast cancer: a population-based study.
Zhao Z; Zhang T; Yao Y; Lu X
BMC Surg; 2022 Apr; 22(1):143. PubMed ID: 35430796
[TBL] [Abstract][Full Text] [Related]
11. Influence of progesterone receptor on metastasis and prognosis in breast cancer patients with negative HER-2.
Xiao Y; Li J; Wu Z; Zhang X; Ming J
Gland Surg; 2022 Jan; 11(1):77-90. PubMed ID: 35242671
[TBL] [Abstract][Full Text] [Related]
12. Tumor Size Still Impacts Prognosis in Breast Cancer With Extensive Nodal Involvement.
Liu Y; He M; Zuo WJ; Hao S; Wang ZH; Shao ZM
Front Oncol; 2021; 11():585613. PubMed ID: 33898305
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the prognostic stage in the 8th edition of the American Joint Committee on Cancer in locally advanced breast cancer: An analysis based on SEER 18 database.
Wang M; Chen H; Wu K; Ding A; Zhang M; Zhang P
Breast; 2018 Feb; 37():56-63. PubMed ID: 29100045
[TBL] [Abstract][Full Text] [Related]
15. Impact of breast surgery on survival of patients with stage IV breast cancer: a SEER population-based propensity score matching analysis.
Lin Y; Huang K; Zeng Q; Zhang J; Song C
PeerJ; 2020; 8():e8694. PubMed ID: 32219021
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Benefit of Radiotherapy in Patients with Occult Breast Cancer: A Population-Based Analysis of the SEER Database.
Kim BH; Kwon J; Kim K
Cancer Res Treat; 2018 Apr; 50(2):551-561. PubMed ID: 28602055
[TBL] [Abstract][Full Text] [Related]
17. Different prognosis by subtype in the early mucinous breast cancer: a SEER population-based analysis.
Lian W; Zheng J; Chen D
Transl Cancer Res; 2020 Oct; 9(10):5969-5978. PubMed ID: 35117209
[TBL] [Abstract][Full Text] [Related]
18. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study.
Sohn G; Son BH; Lee SJ; Kang EY; Jung SH; Cho SH; Baek S; Lee YR; Kim HJ; Ko BS; Yu ; Lee JW; Ahn SH
J Surg Oncol; 2014 Sep; 110(3):270-4. PubMed ID: 24863883
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Significance of the Oncotype DX Recurrence Score in T
Wang M; Wu K; Zhang P; Zhang M; Ding A; Chen H
Ann Surg Oncol; 2019 May; 26(5):1227-1235. PubMed ID: 30456680
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
